H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.6% of adults in Stamford have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Census population 135,470. Connecticut Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Stamford clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Stamford storefront.
Platelet Rich Plasma (PRP) Therapy in Stamford, CT for clinics & physicians. PRP therapy systems with 1-mi… Compliance support & pricing — contact Hawk Medical.
Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 8.6% of adults in Stamford have diagnosed diabetes — 3.4 points below the U.S. 12% figure. 12.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick platelet rich plasma therapy against that mix.
National Platelet Rich Plasma (PRP) Therapy notes (how the product actually works)JK reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Stamford is 8.6% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, JK articles mapped. 12.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 8.6% of adults — 3.4 points below the U.S. 12% figure. Obesity is 25.5%; arthritis is 19.3%. That is place-level BRFSS modeling, not a clinic census and not a Stamford trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Connecticut compliance risk.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Connecticut.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in Stamford.
Ask for the IFU, the lot-traceability packet, and the National Government Services (NGS) article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Stamford fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Stamford, CT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Stamford is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Stamford — 3.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Connecticut Part B wound biologics follow this contractor (siblings: MA, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Stamford. Useful for joint-program math; still needs a diagnosis and privileging.
No Stamford storefront. Joe Bradley is an active practice owner. platelet rich plasma therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.